Hatem Soliman, MD

Hatem Soliman, MD, discusses the utility of antibody-drug conjugates in breast cancer.

Hatem Soliman, MD, discusses the rationale for using immunotherapy in triple-negative breast cancer.

Hatem Soliman, MD, medical oncologist, The Center for Women’s Oncology, Moffitt Cancer Center, discusses the use of combination therapies in the treatment of patients with breast cancer.

Hatem Soliman, MD, associate member of The Center for Women’s Oncology at the Moffitt Cancer Center discusses the prospective registry IMPACt study, which measured the impact of the MammaPrint 70-gene Breast Cancer Recurrence Assay in the routine management of women with early-stage breast cancer.